Insulin infusion reduces hepatocyte growth factor in lean humans

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Insulin infusion reduces hepatocyte growth factor in lean humans. / de Courten, Barbora; de Courten, Maximilian; Dougherty, Sonia; Forbes, Josephine M; Potts, Jenna R; Considine, Robert V.

I: Metabolism, Bind 62, Nr. 5, 05.2013, s. 647-650.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

de Courten, B, de Courten, M, Dougherty, S, Forbes, JM, Potts, JR & Considine, RV 2013, 'Insulin infusion reduces hepatocyte growth factor in lean humans', Metabolism, bind 62, nr. 5, s. 647-650. https://doi.org/10.1016/j.metabol.2012.10.013

APA

de Courten, B., de Courten, M., Dougherty, S., Forbes, J. M., Potts, J. R., & Considine, R. V. (2013). Insulin infusion reduces hepatocyte growth factor in lean humans. Metabolism, 62(5), 647-650. https://doi.org/10.1016/j.metabol.2012.10.013

Vancouver

de Courten B, de Courten M, Dougherty S, Forbes JM, Potts JR, Considine RV. Insulin infusion reduces hepatocyte growth factor in lean humans. Metabolism. 2013 maj;62(5):647-650. https://doi.org/10.1016/j.metabol.2012.10.013

Author

de Courten, Barbora ; de Courten, Maximilian ; Dougherty, Sonia ; Forbes, Josephine M ; Potts, Jenna R ; Considine, Robert V. / Insulin infusion reduces hepatocyte growth factor in lean humans. I: Metabolism. 2013 ; Bind 62, Nr. 5. s. 647-650.

Bibtex

@article{e3035376128349b5b1d6d1d81ed9e2a2,
title = "Insulin infusion reduces hepatocyte growth factor in lean humans",
abstract = "OBJECTIVE: Plasma Hepatocyte Growth Factor (HGF) is significantly elevated in obesity and may contribute to vascular disease, metabolic syndrome or cancer in obese individuals. The current studies were done to determine if hyperinsulinemia increases plasma HGF. MATERIALS/METHODS: Twenty-two participants (10 women/12 men, BMI 20.6-34.5 kg/m(2), age 18-49 years) underwent a hyperinsulinemic euglycemic clamp with measurement of HGF at baseline and steady state. Relationships between baseline HGF, anthropometrics, triglycerides, liver enzymes, c-reactive protein and adiponectin were also evaluated. RESULTS: Fasting HGF was positively correlated (P",
author = "{de Courten}, Barbora and {de Courten}, Maximilian and Sonia Dougherty and Forbes, {Josephine M} and Potts, {Jenna R} and Considine, {Robert V}",
note = "Copyright {\textcopyright} 2012 Elsevier Inc. All rights reserved.",
year = "2013",
month = may,
doi = "10.1016/j.metabol.2012.10.013",
language = "English",
volume = "62",
pages = "647--650",
journal = "Metabolism",
issn = "0026-0495",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Insulin infusion reduces hepatocyte growth factor in lean humans

AU - de Courten, Barbora

AU - de Courten, Maximilian

AU - Dougherty, Sonia

AU - Forbes, Josephine M

AU - Potts, Jenna R

AU - Considine, Robert V

N1 - Copyright © 2012 Elsevier Inc. All rights reserved.

PY - 2013/5

Y1 - 2013/5

N2 - OBJECTIVE: Plasma Hepatocyte Growth Factor (HGF) is significantly elevated in obesity and may contribute to vascular disease, metabolic syndrome or cancer in obese individuals. The current studies were done to determine if hyperinsulinemia increases plasma HGF. MATERIALS/METHODS: Twenty-two participants (10 women/12 men, BMI 20.6-34.5 kg/m(2), age 18-49 years) underwent a hyperinsulinemic euglycemic clamp with measurement of HGF at baseline and steady state. Relationships between baseline HGF, anthropometrics, triglycerides, liver enzymes, c-reactive protein and adiponectin were also evaluated. RESULTS: Fasting HGF was positively correlated (P

AB - OBJECTIVE: Plasma Hepatocyte Growth Factor (HGF) is significantly elevated in obesity and may contribute to vascular disease, metabolic syndrome or cancer in obese individuals. The current studies were done to determine if hyperinsulinemia increases plasma HGF. MATERIALS/METHODS: Twenty-two participants (10 women/12 men, BMI 20.6-34.5 kg/m(2), age 18-49 years) underwent a hyperinsulinemic euglycemic clamp with measurement of HGF at baseline and steady state. Relationships between baseline HGF, anthropometrics, triglycerides, liver enzymes, c-reactive protein and adiponectin were also evaluated. RESULTS: Fasting HGF was positively correlated (P

U2 - 10.1016/j.metabol.2012.10.013

DO - 10.1016/j.metabol.2012.10.013

M3 - Journal article

C2 - 23190875

VL - 62

SP - 647

EP - 650

JO - Metabolism

JF - Metabolism

SN - 0026-0495

IS - 5

ER -

ID: 43232861